Hematology and Oncology Flashcards
7 cards from real ITE practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Hematology and Oncology flashcards as text
A 72-year-old man with CLL has a rising lymphocyte count and new lymphadenopathy. Biopsy shows transformation to DLBCL with loss of CD5 expression and elevated LDH. What is this transformation called?
Answer: Richter transformation
Richter transformation refers to the development of aggressive lymphoma (most commonly DLBCL) in a patient with CLL, carrying a poor prognosis.
A patient with AML achieves complete remission after induction chemotherapy. Cytogenetics show inv(16). Which post-remission strategy is preferred?
Answer: High-dose cytarabine consolidation
Inv(16) is a favorable-risk cytogenetic abnormality in AML; high-dose cytarabine consolidation achieves excellent outcomes without the added toxicity of transplant.
A 50-year-old woman presents with venous thrombosis at an unusual site (portal vein). Testing reveals the JAK2 V617F mutation. What underlying condition is most likely?
Answer: Myeloproliferative neoplasm (polycythemia vera)
JAK2 V617F is found in ~95% of polycythemia vera cases and is the most common MPN associated with splanchnic vein thrombosis.
A 25-year-old man presents with bilateral testicular germ cell tumor markers showing elevated AFP and beta-hCG. Staging CT shows retroperitoneal lymph nodes up to 3 cm but no visceral metastases. What is the first-line treatment?
Answer: Orchiectomy followed by BEP chemotherapy
For intermediate or high-risk nonseminomatous GCT with elevated markers and lymph node involvement, orchiectomy followed by BEP (bleomycin, etoposide, cisplatin) is standard.
A patient receiving cisplatin-based chemotherapy develops a serum creatinine rise from 0.9 to 2.1 mg/dL. Urinalysis shows granular casts and low urine sodium. What is the mechanism of nephrotoxicity?
Answer: Direct proximal tubular cell injury
Cisplatin causes direct proximal tubular injury through accumulation of platinum-DNA adducts, leading to tubular necrosis.
A 40-year-old woman with myelodysplastic syndrome has a del(5q) as the sole cytogenetic abnormality, transfusion-dependent anemia, and platelet count of 450,000/μL. Which agent is specifically indicated?
Answer: Lenalidomide
Lenalidomide is specifically approved for transfusion-dependent MDS with isolated del(5q) and produces high rates of transfusion independence.
A 55-year-old man with metastatic renal cell carcinoma (clear cell histology) has good performance status and no prior therapy. Which combination is preferred first-line based on current evidence?
Answer: Nivolumab plus ipilimumab or pembrolizumab plus axitinib
Checkpoint inhibitor-based combinations (e.g., nivolumab/ipilimumab or pembrolizumab/axitinib) have demonstrated superior overall survival compared to sunitinib in first-line clear-cell RCC.